Patent · US Expired

Anti-PECAM therapy for metastasis suppression

US7572443B2 · kind B2 · utility

0Cited by
12References
11Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 12, 2004
Grant dateAug 11, 2009
Priority date
Expiry dateNov 12, 2024

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/73
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides novel compositions, methods, kits, and uses thereof relating to antimetastatic agents useful for treating neoplastic diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.